Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

The critical role of angiogenesis in promoting tumor growth and metastasis is strongly established. However, tumors show considerable variation in angiogenic characteristics and in their sensitivity to antiangiogenic therapy. Tumor angiogenesis involves not only cancer cells but also various tumor-associated leukocytes (TALs) and stromal cells. TALs produce chemokines, cytokines, proteases, structural proteins, and microvescicles. Vascular endothelial growth factor (VEGF) and inflammatory chemokines are not only major proangiogenic factors but are also immune modulators, which increase angiogenesis and lead to immune suppression. In our review, we discuss the regulation of angiogenesis by innate immune cells in the tumor microenvironment, specific features, and roles of major players: macrophages, neutrophils, myeloid-derived suppressor and dendritic cells, mast cells, γδT cells, innate lymphoid cells, and natural killer cells. Anti-VEGF or anti-inflammatory drugs could balance an immunosuppressive microenvironment to an immune permissive one. Anti-VEGF as well as anti-inflammatory drugs could therefore represent partners for combinations with immune checkpoint inhibitors, enhancing the effects of immune therapy.

Original languageEnglish
Article number527
JournalFrontiers in Immunology
Volume9
Issue numberAPR
DOIs
Publication statusPublished - Apr 5 2018

Fingerprint

Tumor Microenvironment
Immunotherapy
Vascular Endothelial Growth Factor A
Neoplasms
Chemokines
Leukocytes
Anti-Inflammatory Agents
Immunologic Factors
Immunosuppressive Agents
Stromal Cells
Mast Cells
Natural Killer Cells
Pharmaceutical Preparations
Dendritic Cells
Neutrophils
Peptide Hydrolases
Macrophages
Lymphocytes
Cytokines
Neoplasm Metastasis

Keywords

  • Angiogenesis
  • Chemoprevention
  • Immune cells
  • Immunotherapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{27feee73bda94c3ba5be5cf0c2747b05,
title = "Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy",
abstract = "The critical role of angiogenesis in promoting tumor growth and metastasis is strongly established. However, tumors show considerable variation in angiogenic characteristics and in their sensitivity to antiangiogenic therapy. Tumor angiogenesis involves not only cancer cells but also various tumor-associated leukocytes (TALs) and stromal cells. TALs produce chemokines, cytokines, proteases, structural proteins, and microvescicles. Vascular endothelial growth factor (VEGF) and inflammatory chemokines are not only major proangiogenic factors but are also immune modulators, which increase angiogenesis and lead to immune suppression. In our review, we discuss the regulation of angiogenesis by innate immune cells in the tumor microenvironment, specific features, and roles of major players: macrophages, neutrophils, myeloid-derived suppressor and dendritic cells, mast cells, γδT cells, innate lymphoid cells, and natural killer cells. Anti-VEGF or anti-inflammatory drugs could balance an immunosuppressive microenvironment to an immune permissive one. Anti-VEGF as well as anti-inflammatory drugs could therefore represent partners for combinations with immune checkpoint inhibitors, enhancing the effects of immune therapy.",
keywords = "Angiogenesis, Chemoprevention, Immune cells, Immunotherapy, Tumor microenvironment",
author = "Adriana Albini and Antonino Bruno and Noonan, {Douglas M.} and Lorenzo Mortara",
year = "2018",
month = "4",
day = "5",
doi = "10.3389/fimmu.2018.00527",
language = "English",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "APR",

}

TY - JOUR

T1 - Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment

T2 - Implications for immunotherapy

AU - Albini, Adriana

AU - Bruno, Antonino

AU - Noonan, Douglas M.

AU - Mortara, Lorenzo

PY - 2018/4/5

Y1 - 2018/4/5

N2 - The critical role of angiogenesis in promoting tumor growth and metastasis is strongly established. However, tumors show considerable variation in angiogenic characteristics and in their sensitivity to antiangiogenic therapy. Tumor angiogenesis involves not only cancer cells but also various tumor-associated leukocytes (TALs) and stromal cells. TALs produce chemokines, cytokines, proteases, structural proteins, and microvescicles. Vascular endothelial growth factor (VEGF) and inflammatory chemokines are not only major proangiogenic factors but are also immune modulators, which increase angiogenesis and lead to immune suppression. In our review, we discuss the regulation of angiogenesis by innate immune cells in the tumor microenvironment, specific features, and roles of major players: macrophages, neutrophils, myeloid-derived suppressor and dendritic cells, mast cells, γδT cells, innate lymphoid cells, and natural killer cells. Anti-VEGF or anti-inflammatory drugs could balance an immunosuppressive microenvironment to an immune permissive one. Anti-VEGF as well as anti-inflammatory drugs could therefore represent partners for combinations with immune checkpoint inhibitors, enhancing the effects of immune therapy.

AB - The critical role of angiogenesis in promoting tumor growth and metastasis is strongly established. However, tumors show considerable variation in angiogenic characteristics and in their sensitivity to antiangiogenic therapy. Tumor angiogenesis involves not only cancer cells but also various tumor-associated leukocytes (TALs) and stromal cells. TALs produce chemokines, cytokines, proteases, structural proteins, and microvescicles. Vascular endothelial growth factor (VEGF) and inflammatory chemokines are not only major proangiogenic factors but are also immune modulators, which increase angiogenesis and lead to immune suppression. In our review, we discuss the regulation of angiogenesis by innate immune cells in the tumor microenvironment, specific features, and roles of major players: macrophages, neutrophils, myeloid-derived suppressor and dendritic cells, mast cells, γδT cells, innate lymphoid cells, and natural killer cells. Anti-VEGF or anti-inflammatory drugs could balance an immunosuppressive microenvironment to an immune permissive one. Anti-VEGF as well as anti-inflammatory drugs could therefore represent partners for combinations with immune checkpoint inhibitors, enhancing the effects of immune therapy.

KW - Angiogenesis

KW - Chemoprevention

KW - Immune cells

KW - Immunotherapy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85045005911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045005911&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.00527

DO - 10.3389/fimmu.2018.00527

M3 - Review article

AN - SCOPUS:85045005911

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

M1 - 527

ER -